Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 4
2018 1
2019 4
2020 3
2021 3
2022 7
2023 3
2024 2
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.
Acute Gout Sacroiliitis.
Kaly L, Bilder I, Rozenbaum M, Boulman N, Rimar D, Awisat A, Rosner I, Hussein H, Silawy A, Gaspar T, Slobodin G. Kaly L, et al. Among authors: awisat a. Isr Med Assoc J. 2021 Mar;23(3):191-192. Isr Med Assoc J. 2021. PMID: 33734634 Free article. No abstract available.
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
Mekinian A, Biard L, Lorenzo D, Novikov PI, Salvarani C, Espitia O, Sciascia S, Michaud M, Lambert M, Hernández-Rodríguez J, Schleinitz N, Awisat A, Puechal X, Aouba A, Munoz Pons H, Smitienko I, Gaultier JB, Edwige LM, Benhamou Y, Perlat A, Jego P, Goulenok T, Sacre K, Lioger B, Hassold N, Broner J, Dufrost V, Sené T, Seguier J, Maurier F, Berthier S, Belot A, Frikha F, Denis G, Audemard-Verger A, Koné-Paut I, Humbert S, Woaye-Hune P, Tomelleri A, Baldissera EM, Kuwana M, Lo Gullo A, Mukuchyan V, Dellal A, Gaches F, Zeminsky P, Galli E, Alvarado M, Boiardi L, Muratore F, Vautier M, Campochiaro C, Moiseev S, Vieira M, Cacoub P, Fain O, Saadoun D; French Takayasu network. Mekinian A, et al. Among authors: awisat a. RMD Open. 2023 Jun;9(2):e002830. doi: 10.1136/rmdopen-2022-002830. RMD Open. 2023. PMID: 37321669 Free PMC article.
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosis.
Keret S, Kaly L, Schett G, Bergmann C, Feldman E, Zuckerman T, Yehudai-Ofir D, Shouval A, Awisat A, Rosner I, Rozenbaum M, Boulman N, Sawaed A, Hardak E, Henes J, Slobodin G, Rimar D. Keret S, et al. Among authors: awisat a. Rheumatology (Oxford). 2025 May 1;64(5):3160-3165. doi: 10.1093/rheumatology/keae606. Rheumatology (Oxford). 2025. PMID: 39485492
Autoinflammatory associated vasculitis.
Ginsberg S, Rosner I, Rozenbaum M, Slobodin G, Zilber K, Boulman N, Kaly L, Awisat A, Jiries N, Beyar-Katz O, Rimar D. Ginsberg S, et al. Among authors: awisat a. Semin Arthritis Rheum. 2016 Dec;46(3):367-371. doi: 10.1016/j.semarthrit.2016.07.007. Epub 2016 Jul 20. Semin Arthritis Rheum. 2016. PMID: 27612399
Response to a letter by M. Slouma et al.
Sagiv M, Adawi M, Awisat A, Shouval A, Peri R, Sabbah F, Rosner I, Kessel A, Slobodin G. Sagiv M, et al. Among authors: awisat a. Int J Rheum Dis. 2022 Feb;25(2):238. doi: 10.1111/1756-185X.14274. Epub 2021 Dec 30. Int J Rheum Dis. 2022. PMID: 34970855 No abstract available.
Infliximab for the treatment of refractory polyarteritis nodosa.
Ginsberg S, Rosner I, Slobodin G, Rozenbaum M, Kaly L, Jiries N, Boulman N, Awisat A, Hussein H, Novofastovski I, Silawy A, Rimar D. Ginsberg S, et al. Among authors: awisat a. Clin Rheumatol. 2019 Oct;38(10):2825-2833. doi: 10.1007/s10067-019-04474-9. Epub 2019 Apr 10. Clin Rheumatol. 2019. PMID: 30972576 Review.
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study.
Mekinian A, Meneses S, Biard L, Dagna L, Novikov P, Salvarani C, Espitia O, Sciscia S, Michaud M, Lambert M, Hernández-Rodríguez J, Schleinitz N, Awisat A, Puéchal X, Aouba A, Munoz Pons H, Smitienko I, Gaultier JB, Edwige LM, Benhamou Y, Perlat A, Jego P, Goulenok T, Sacre K, Lioger B, Hassold N, Broner J, Dufrost V, Sene T, Seguier J, Maurier F, Berthier S, Belot A, Frikha F, Denis G, Audemard-Verger A, Koné-Paut I, Humbert S, Woaye-Hune P, Tomelleri A, Baldissera E, Kuwana M, Lo Gullo A, Mukuchyan V, Dellal A, Gaches F, Zeminsky P, Marvisi C, Alvarado M, Boiardi L, Muratore F, Vautier M, Campochiaro C, Moiseev S, Vieira M, Cacoub P, Fain O, Saadoun D; French Takayasu network. Mekinian A, et al. Among authors: awisat a. Rheumatology (Oxford). 2025 Aug 14:keaf341. doi: 10.1093/rheumatology/keaf341. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40811657
29 results